Archive for August, 2019

Misonix (NASDAQ:MSON) Earns Buy Rating from Canaccord Genuity

Canaccord Genuity reiterated their buy rating on shares of Misonix (NASDAQ:MSON) in a report published on Thursday morning, The Fly reports. They currently have a $30.00 price objective on the medical equipment provider’s stock, up from their prior price objective of $24.00. MSON has been the topic of a number of other reports. TheStreet downgraded […]

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Rating Reaffirmed by Wedbush

Wedbush reissued their buy rating on shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) in a research report sent to investors on Wednesday, AnalystRatings.com reports. Wedbush also issued estimates for Kiniksa Pharmaceuticals’ Q3 2019 earnings at ($0.75) EPS, Q4 2019 earnings at ($0.83) EPS, FY2019 earnings at ($3.54) EPS, Q1 2020 earnings at ($0.82) EPS, Q2 2020 earnings […]

Liberty Media Formula One Series A (NASDAQ:FWONA) Raised to Overweight at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of Liberty Media Formula One Series A (NASDAQ:FWONA) from a neutral rating to an overweight rating in a research note published on Thursday, Briefing.com Automated Import reports. They currently have $50.00 price objective on the stock, up from their previous price objective of $38.00. Other research analysts have also […]

Horizon Therapeutics (NASDAQ:HZNP) Stock Rating Upgraded by BMO Capital Markets

BMO Capital Markets upgraded shares of Horizon Therapeutics (NASDAQ:HZNP) from a market perform rating to an outperform rating in a report published on Wednesday, BenzingaRatingsTable reports. They currently have $36.00 target price on the biopharmaceutical company’s stock, up from their previous target price of $29.00. Several other equities research analysts also recently issued reports on […]

Constellation Pharmaceuticals (NASDAQ:CNST) Downgraded to “Hold” at Zacks Investment Research

Zacks Investment Research lowered shares of Constellation Pharmaceuticals (NASDAQ:CNST) from a buy rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, “Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company’s lead […]

Energizer Holdings Inc Plans Quarterly Dividend of $0.30 (NYSE:ENR)

Energizer Holdings Inc (NYSE:ENR) declared a quarterly dividend on Monday, July 29th, RTT News reports. Stockholders of record on Tuesday, August 20th will be given a dividend of 0.30 per share on Tuesday, September 10th. This represents a $1.20 annualized dividend and a dividend yield of 3.30%. The ex-dividend date is Monday, August 19th. Energizer […]

Ashford Hospitality Trust (NYSE:AHT) Receives “Buy” Rating from Deutsche Bank

Deutsche Bank restated their buy rating on shares of Ashford Hospitality Trust (NYSE:AHT) in a report published on Wednesday, AnalystRatings.com reports. The firm currently has a $5.00 price target on the real estate investment trust’s stock. AHT has been the subject of several other research reports. Zacks Investment Research raised Ashford Hospitality Trust from a […]

B. Riley Cuts ConturaEnergyInc . (NASDAQ:CTRA) Price Target to $67.00

ConturaEnergyInc . (NASDAQ:CTRA) had its price target lowered by B. Riley from $80.00 to $67.00 in a research note issued to investors on Thursday, BenzingaRatingsTable reports. The brokerage currently has a buy rating on the stock. CTRA has been the topic of several other reports. Zacks Investment Research raised ConturaEnergyInc . from a strong sell […]

Reverse Corp Limited (REF) to Issue Interim Dividend of $0.03 on September 2nd

Reverse Corp Limited (ASX:REF) declared a interim dividend on Friday, August 16th, MarketIndexAU reports. Investors of record on Monday, September 2nd will be given a dividend of 0.028 per share on Monday, September 2nd. This represents a yield of 68.75%. The ex-dividend date is Tuesday, August 20th. ASX:REF opened at A$0.04 ($0.03) on Friday. The […]

Ambac Financial Group (NASDAQ:AMBC) Upgraded at BidaskClub

BidaskClub upgraded shares of Ambac Financial Group (NASDAQ:AMBC) from a buy rating to a strong-buy rating in a research report report published on Thursday morning, BidAskClub reports. Other equities analysts have also issued reports about the stock. BTIG Research reiterated a buy rating and set a $26.00 target price on shares of Ambac Financial Group […]

People’s United Financial (NASDAQ:PBCT) Downgraded by BidaskClub

BidaskClub downgraded shares of People’s United Financial (NASDAQ:PBCT) from a hold rating to a sell rating in a report published on Thursday morning, BidAskClub reports. PBCT has been the topic of several other reports. FIG Partners lowered shares of People’s United Financial from an outperform rating to a market perform rating in a research note […]

Reaves Utility Income Fund (UTG) To Go Ex-Dividend on August 20th

Reaves Utility Income Fund (NYSEAMERICAN:UTG) declared a monthly dividend on Tuesday, June 18th, Wall Street Journal reports. Stockholders of record on Wednesday, August 21st will be given a dividend of 0.18 per share by the closed-end fund on Friday, August 30th. This represents a $2.16 dividend on an annualized basis and a dividend yield of […]

BIOLASE (NASDAQ:BIOL) Raised to Buy at ValuEngine

ValuEngine upgraded shares of BIOLASE (NASDAQ:BIOL) from a hold rating to a buy rating in a report released on Thursday morning, ValuEngine reports. Several other equities analysts also recently weighed in on the stock. Benchmark began coverage on shares of BIOLASE in a report on Wednesday, June 19th. They issued a speculative buy rating and […]

JBS S A/S (OTCMKTS:JBSAY) Lifted to Overweight at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of JBS S A/S (OTCMKTS:JBSAY) from a neutral rating to an overweight rating in a research report report published on Thursday morning, The Fly reports. JBSAY has been the subject of a number of other reports. Barclays upgraded JBS S A/S from an equal weight rating to an overweight […]

Trevi Therapeutics (NASDAQ:TRVI) Downgraded to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Trevi Therapeutics (NASDAQ:TRVI) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “Trevi Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. The company […]

Kirkland Lake Gold (TSE:KL) Price Target Raised to C$65.00

Kirkland Lake Gold (TSE:KL) had its target price lifted by National Bank Financial from C$63.00 to C$65.00 in a research note released on Wednesday morning, BayStreet.CA reports. They currently have a sector perform rating on the stock. Other analysts have also recently issued reports about the company. Eight Capital boosted their price target on Kirkland […]

Viacom (NASDAQ:VIA) Rating Increased to Buy at Guggenheim

Guggenheim upgraded shares of Viacom (NASDAQ:VIA) from a neutral rating to a buy rating in a report released on Wednesday morning, The Fly reports. A number of other analysts have also commented on the stock. BidaskClub lowered shares of Viacom from a hold rating to a sell rating in a research note on Tuesday, June […]

Contrasting HL Acquisition (NASDAQ:HCCH) & AgroFresh Solutions (NASDAQ:AGFS)

HL Acquisition (NASDAQ:HCCH) and AgroFresh Solutions (NASDAQ:AGFS) are both small-cap unclassified companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Analyst Ratings This is a breakdown of recent recommendations for HL Acquisition and AgroFresh Solutions, […]

Financial Analysis: QC (OTCMKTS:QCCO) and Usio (OTCMKTS:USIO)

QC (OTCMKTS:QCCO) and Usio (NASDAQ:USIO) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends. Volatility & Risk QC has a beta of 2.17, meaning that its stock price is 117% more volatile […]

Head-To-Head Survey: Landstar (OTCMKTS:LDSR) & Braskem (OTCMKTS:BRKMY)

Landstar (OTCMKTS:LDSR) and Braskem (OTCMKTS:BRKMY) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership. Profitability This table compares Landstar and Braskem’s net margins, return on equity and return on assets. Net […]

Myriad Genetics (NASDAQ:MYGN) Price Target Lowered to $35.00 at Deutsche Bank

Myriad Genetics (NASDAQ:MYGN) had its target price lowered by Deutsche Bank from $45.00 to $35.00 in a research report report published on Wednesday, The Fly reports. The firm currently has a hold rating on the stock. A number of other analysts also recently commented on MYGN. Barclays upgraded Myriad Genetics from an underweight rating to […]

Goldman Sachs Group Initiates Coverage on Tenet Healthcare (NYSE:THC)

Goldman Sachs Group started coverage on shares of Tenet Healthcare (NYSE:THC) in a research note published on Wednesday, BenzingaRatingsTable reports. The brokerage issued a neutral rating and a $28.00 price target on the stock. A number of other research firms also recently issued reports on THC. Barclays set a $24.00 price objective on shares of […]

OMV (OTCMKTS:OMVKY) Downgraded by Goldman Sachs Group to Neutral

Goldman Sachs Group cut shares of OMV (OTCMKTS:OMVKY) from a buy rating to a neutral rating in a research note released on Wednesday morning, The Fly reports. Separately, Barclays lowered OMV from an overweight rating to an equal weight rating in a report on Wednesday, July 31st. Shares of OMV stock opened at $48.85 on […]

Stifel Nicolaus Reiterates “Buy” Rating for NGM Biopharmaceuticals (NYSE:NGM)

Stifel Nicolaus reissued their buy rating on shares of NGM Biopharmaceuticals (NYSE:NGM) in a research note published on Wednesday morning, AnalystRatings.com reports. They currently have a $26.00 price objective on the stock. “We are reiterating our Buy rating and $26 target price after NGM reported its 2Q19 financials and business update. We remain positively biased […]

Piedmont Office Realty Trust (NYSE:PDM) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Piedmont Office Realty Trust (NYSE:PDM) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, “Piedmont Office Realty Trust, Inc. is an integrated and self-managed real estate investment trust specializing in the acquisition, ownership, management and development of commercial […]

Critical Comparison: BEST (NYSE:BEST) and ZTO Express (Cayman) (NYSE:ZTO)

BEST (NYSE:BEST) and ZTO Express (Cayman) (NYSE:ZTO) are both transportation companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership. Volatility & Risk BEST has a beta of 1.2, meaning that its share price is 20% […]

Jadestone Energy (LON:JSE) Earns Buy Rating from Analysts at Berenberg Bank

Berenberg Bank initiated coverage on shares of Jadestone Energy (LON:JSE) in a research note issued to investors on Wednesday, Digital Look reports. The firm issued a buy rating and a GBX 110 ($1.44) price target on the stock. JSE stock opened at GBX 55 ($0.72) on Wednesday. The firm has a 50 day moving average […]

Total Energy Services (TSE:TOT) Rating Lowered to Sector Perform at AltaCorp Capital

AltaCorp Capital downgraded shares of Total Energy Services (TSE:TOT) from an outperform rating to a sector perform rating in a research note published on Wednesday, BayStreet.CA reports. They currently have C$7.75 target price on the stock, down from their previous target price of C$11.50. TOT has been the topic of a number of other research […]

Goldman Sachs Group Trims Rolls-Royce Holding PLC (LON:RR) Target Price to GBX 1,239

Rolls-Royce Holding PLC (LON:RR) had its target price decreased by Goldman Sachs Group from GBX 1,367 ($17.86) to GBX 1,239 ($16.19) in a research report sent to investors on Thursday morning, ThisIsMoney.Co.Uk reports. Goldman Sachs Group currently has a conviction-buy rating on the stock. A number of other equities analysts have also recently issued reports […]

Contrasting Shotspotter (NASDAQ:SSTI) and 2U (NASDAQ:TWOU)

Shotspotter (NASDAQ:SSTI) and 2U (NASDAQ:TWOU) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability. Earnings and Valuation This table compares Shotspotter and 2U’s top-line revenue, earnings per share and valuation. […]

Tecnoglass (NASDAQ:TGLS) Upgraded at BidaskClub

BidaskClub upgraded shares of Tecnoglass (NASDAQ:TGLS) from a sell rating to a hold rating in a research report report published on Wednesday morning, BidAskClub reports. Several other research firms have also recently weighed in on TGLS. Goldman Sachs Group began coverage on Tecnoglass in a research note on Thursday, May 9th. They set a buy […]

Mesa Laboratories (NASDAQ:MLAB) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Mesa Laboratories (NASDAQ:MLAB) from a sell rating to a buy rating in a report released on Wednesday, Zacks.com reports. The brokerage currently has $244.00 price target on the medical instruments supplier’s stock. According to Zacks, “MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in […]

RadNet (NASDAQ:RDNT) Upgraded at BidaskClub

BidaskClub upgraded shares of RadNet (NASDAQ:RDNT) from a buy rating to a strong-buy rating in a research report released on Wednesday morning, BidAskClub reports. A number of other equities analysts have also commented on the company. TheStreet lowered RadNet from a b- rating to a c rating in a research note on Tuesday, June 4th. […]

Financial Survey: Precision Therapeutics (NASDAQ:POAI) versus ConforMIS (NASDAQ:CFMS)

Precision Therapeutics (NASDAQ:POAI) and ConforMIS (NASDAQ:CFMS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership. Institutional and Insider Ownership 1.1% of Precision Therapeutics shares are held by institutional investors. Comparatively, 34.3% […]

JPMorgan Chase & Co. Analysts Give AstraZeneca (LON:AZN) a GBX 7,900 Price Target

JPMorgan Chase & Co. set a GBX 7,900 ($103.23) target price on AstraZeneca (LON:AZN) in a research report report published on Thursday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. AZN has been the subject of several other research reports. Jefferies Financial Group decreased their target price […]

Monster Beverage (NASDAQ:MNST) Downgraded by BidaskClub

BidaskClub lowered shares of Monster Beverage (NASDAQ:MNST) from a strong-buy rating to a buy rating in a report released on Wednesday, BidAskClub reports. Other analysts have also issued reports about the stock. Zacks Investment Research raised shares of Monster Beverage from a sell rating to a hold rating in a research note on Tuesday, May […]

Activision Blizzard (NASDAQ:ATVI) Rating Lowered to Hold at BidaskClub

BidaskClub cut shares of Activision Blizzard (NASDAQ:ATVI) from a buy rating to a hold rating in a research report sent to investors on Wednesday, BidAskClub reports. Other analysts have also issued reports about the stock. Nomura initiated coverage on shares of Activision Blizzard in a research report on Thursday, June 6th. They issued a neutral […]

BidaskClub Upgrades Corbus Pharmaceuticals (NASDAQ:CRBP) to Sell

BidaskClub upgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP) from a strong sell rating to a sell rating in a report released on Wednesday morning, BidAskClub reports. A number of other brokerages have also commented on CRBP. ValuEngine lowered Corbus Pharmaceuticals from a strong-buy rating to a buy rating in a research report on Friday, August 2nd. […]

Forrester Research (NASDAQ:FORR) Downgraded to Strong Sell at BidaskClub

BidaskClub lowered shares of Forrester Research (NASDAQ:FORR) from a sell rating to a strong sell rating in a research report released on Wednesday, BidAskClub reports. FORR has been the subject of a number of other research reports. Maxim Group restated a buy rating and set a $59.00 price target (down previously from $62.00) on shares […]

Akorn (NASDAQ:AKRX) Stock Rating Lowered by BidaskClub

BidaskClub lowered shares of Akorn (NASDAQ:AKRX) from a sell rating to a strong sell rating in a research report report published on Wednesday morning, BidAskClub reports. AKRX has been the subject of several other reports. Zacks Investment Research lowered Akorn from a buy rating to a hold rating in a report on Tuesday, July 16th. […]